Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
3
×
Tags
biofourmis
3
×
biotech
boston blog main
boston top stories
3
×
clinical trials
fda
life sciences
medical devices
national blog main
national top stories
3
×
san francisco blog main
san francisco top stories
abbvie
boulder/denver blog main
boulder/denver top stories
chronic kidney disease
detroit blog main
detroit top stories
europe blog main
europe top stories
glaxosmithkline
indiana blog main
indiana top stories
national
new york blog main
new york top stories
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
sanofi
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
acceleron pharma
acid sphingomyelinase deficiency
What
bio
biofourmis
roundup
therapeutics
abbvie’s
ahead
analytics
black
bucks
cancer
celebrate
chance
companies
continue
corner
data
day
days
debut
devices
diamond
diamond’s
digital
employs
forward
globally
hauls
help
holiday
indication
labor
leading
life
looking
mammoth
march
million
moves
ohana’s
patients
Language
unset
Current search:
biofourmis
×
photo
×
" boston top stories "
×
" national top stories "
×
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More